Zobrazeno 1 - 10
of 35
pro vyhledávání: '"T. R. Beam"'
Autor:
Stanley J. Cryz, C. M. Haakenson, Carolyn H. Welsh, E J Young, Carol A. Kauffman, Peter Peduzzi, D Slagle, R T Ellison rd, D Elliston, Suzanne F. Bradley, Richard J. Hamill, R Cantey, T R Beam, Mark J. Mulligan, G Gafford, J M Griffiss, E Abrutyn, Roland M. H. Schein, C Johnson, Alan S. Cross, Bruce S. Ribner, H Leaf, Sam T. Donta, Joseph F. John, Jerald C. Sadoff
Publikováno v:
Journal of Infectious Diseases. 174:537-543
To determine if passive immunization could decrease the incidence or severity of Klebsiella and Pseudomonas aeruginosa infections, patients admitted to intensive care units of 16 Department of Veterans Affairs and Department of Defense hospitals were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::decd9ad51da6aac2c1988e5bdb22d3b0
https://doi.org/10.1093/infdis/174.3.537
https://doi.org/10.1093/infdis/174.3.537
Publikováno v:
Antimicrobial Agents and Chemotherapy. 37:896-900
The susceptibilities of 316 gram-positive bacteremic isolates to ramoplanin, vancomycin, and teicoplanin and seven other antibiotics were tested. Ramoplanin demonstrated MICs of < or = 0.25 microgram/ml for at least 99% of Staphylococcus aureus isola
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b5851ffe4eae94de7311c7e2c1cb6af
https://doi.org/10.1128/aac.37.4.896
https://doi.org/10.1128/aac.37.4.896
Autor:
D Weinbaum, B Farber, C S Bryan, T R Beam, D N Gerding, Marilyn M. Wagener, J A Korvick, L Schenfeld, Robert M. Lumish, Robert R. Muder
Publikováno v:
Antimicrobial Agents and Chemotherapy. 36:2639-2644
Combination antimicrobial agent therapy has been advocated for treatment of gram-negative bacteremia, including that caused by Klebsiella spp. We performed a prospective, observational, 10-hospital collaborative study to evaluate the efficacy of anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f46b70825a6e383aefe10ba548504437
https://doi.org/10.1128/aac.36.12.2639
https://doi.org/10.1128/aac.36.12.2639
Publikováno v:
American Journal of Public Health. 80:590-593
Health care personnel who received the hepatitis B vaccine (Heptavax-BR, MSD) were followed for persistence of hepatitis B surface antibody (anti-HBs). Response occurred in 135/146 (92.5 percent) vaccinees. Loss of anti-HBs (less than 72 RIA units; 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94e9f2935bc4e57a4cb3d071f2cb3254
https://doi.org/10.2105/ajph.80.5.590
https://doi.org/10.2105/ajph.80.5.590
Autor:
S T, Donta, P, Peduzzi, A S, Cross, J, Sadoff, C, Haakenson, S J, Cryz, C, Kauffman, S, Bradley, G, Gafford, D, Elliston, T R, Beam, J F, John, B, Ribner, R, Cantey, C H, Welsh, R T, Ellison, E J, Young, R J, Hamill, H, Leaf, R M, Schein, M, Mulligan, C, Johnson, E, Abrutyn, J M, Griffiss, D, Slagle
Publikováno v:
The Journal of infectious diseases. 174(3)
To determine if passive immunization could decrease the incidence or severity of Klebsiella and Pseudomonas aeruginosa infections, patients admitted to intensive care units of 16 Department of Veterans Affairs and Department of Defense hospitals were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a3b39d7f8fb0dd6faa7a3bff8ba4586f
https://pubmed.ncbi.nlm.nih.gov/8769611
https://pubmed.ncbi.nlm.nih.gov/8769611
Publikováno v:
The Journal of antimicrobial chemotherapy. 36(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::092441c66e4c2574d6403ba5607deba2
https://pubmed.ncbi.nlm.nih.gov/8626271
https://pubmed.ncbi.nlm.nih.gov/8626271
Autor:
T R, Beam
Publikováno v:
Critical care nursing clinics of North America. 6(2)
Anti-infective drugs may be used to prevent or treat infectious diseases. Preventing serious infections using aerosolized drugs, selective decontamination of the intestinal tract, or devices impregnated with anti-infective materials generally has bee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0ef35ff5b4b12a01b3c00c01f567e044
https://pubmed.ncbi.nlm.nih.gov/7946188
https://pubmed.ncbi.nlm.nih.gov/7946188
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 17(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ff4bca4ca51f81aebe976a8668a269b8
https://pubmed.ncbi.nlm.nih.gov/8268366
https://pubmed.ncbi.nlm.nih.gov/8268366
Autor:
T R, Beam
Publikováno v:
New horizons (Baltimore, Md.). 1(2)
Three fluoroquinolone antimicrobials (norfloxacin, ciprofloxacin, and ofloxacin) could be used to prevent or treat infections in intensive care unit patients. All of these fluoroquinolones are particularly active against Gram-negative, aerobic bacter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9405b2226a2995afff5e7aebb7a2d890
https://pubmed.ncbi.nlm.nih.gov/7922402
https://pubmed.ncbi.nlm.nih.gov/7922402
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 15
This document provides new general guidelines for the design and execution of studies evaluating anti-infective drugs for the prevention or treatment of infectious diseases. The first step in evaluation is the determination of in vitro microbial susc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9589c0e192081b0c4a23765b6e5e48a4
https://pubmed.ncbi.nlm.nih.gov/1477251
https://pubmed.ncbi.nlm.nih.gov/1477251